Role of PET/CT Scanning in Initial and Post-Treatment Assessment of Hodgkin Disease

2008 ◽  
Vol 6 (6) ◽  
pp. 623-632 ◽  
Author(s):  
Sukru Mehmet Erturk ◽  
Annick D. Van den Abbeele

The add-on value of F18-fluorodeoxyglucose PET, particularly when combined with CT, to the conventional workup in managing patients with Hodgkin disease has now been well documented. This article reviews the use of these imaging modalities in the initial staging and post-treatment assessment of Hodgkin disease.

2019 ◽  
Vol 29 (2) ◽  
pp. 266-271
Author(s):  
Chrishanthi Rajasooriyar ◽  
Ming-Yin Lin ◽  
Rashi Kalra ◽  
Andrew Lim ◽  
Kailash Narayan

BackgroundPatients selection for salvage hysterectomy following chemoradiotherapy of cervical cancer is vital to avoid significant morbidity. The purpose of this study was to describe the role of post-treatment F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scanning (FDG-PET/CT) in patient selection for salvage hysterectomy.MethodsThis was a retrospective analysis of 49 patients with cervical cancer treated between January 1996 and December 2012 who were candidates for salvage hysterectomy.ResultsThree groups were defined based on institutional treatment guidelines, as experience in using post-treatment FDG-PET/CT to guide management evolved. Group 1 consisted of 15 patients who underwent planned hysterectomy based on clinical, cytological, or histological suspicion. Of these, only three (20%) patients had residual disease on histology. Group 2 consisted of 13 patients who had post-treatment FDG-PET/CT 3–6 months after the completion of chemoradiotherapy due either to suspicion of recurrence on examination or patients thought to be at high risk of recurrence at the primary site. Of these, eight patients had hysterectomy and four patients showed positive histology for residual tumor. Group 3 had 21 patients who showed isolated FDG uptake at the primary site on first FDG-PET/CT scanning at 6 months. A subsequent FDG-PET/CT scan after 3 months showed disease progression in seven and complete metabolic response in 14, and surgery was avoided in all patients.ConclusionFDG-PET/CT scanning at 6 months after radiotherapy is a good tool for assessing treatment response in patients with cervical cancer. In patients with persistent uptake on 6 months post-treatment FDG-PET/CT, repeat imaging at a 3-month interval helps in selecting patients for salvage hysterectomy.


2020 ◽  
Vol 11 (1) ◽  
pp. 8-12
Author(s):  
Krishna Vedala ◽  
Philip Sobash ◽  
Deborah Johnson ◽  
Krishna Kakkera

PET/CT scans are frequently used in the initial workup of suspicious lesions but not all that lights up on a PET is cancerous. We wish to discuss a case of silicone-induced granuloma mimicking malignancy and the role of other imaging modalities for further workup.


2005 ◽  
Vol 46 (7) ◽  
pp. 716-724 ◽  
Author(s):  
M. E. Mulligan

Radiologists play a central role in the diagnosis, initial staging, follow-up, and restaging of patients with myeloma. This review article attempts to familiarize the reader with all the various types of myeloma, their imaging appearances and useful imaging strategies. The staging system for myeloma patients has been updated and now includes findings from advanced imaging modalities. Radiologists have a vast array of imaging modalities at their disposal to aid them in diagnosis, staging, and follow-up. Currently, conventional radiographic skeletal surveys, magnetic resonance imaging, and F-18 FDG PET/CT examinations are the most useful instruments.


2012 ◽  
Vol 81 (8) ◽  
pp. e817-e822 ◽  
Author(s):  
Hyun Hoon Chung ◽  
Jae Weon Kim ◽  
Keon Wook Kang ◽  
Noh-Hyun Park ◽  
Yong-Sang Song ◽  
...  

Author(s):  
Masaya Akashi ◽  
Satoshi Wanifuchi ◽  
Junya Kusumoto ◽  
Megumi Kishimoto ◽  
Yasumasa Kakei ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document